- Home
- SPTN vs PRTA Comparison
SPTN vs PRTA Comparison
Compare SPTN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- PRTA
- Stock Information
- Founded
- SPTN 1917
- PRTA 2012
- Country
- SPTN United States
- PRTA Ireland
- Employees
- SPTN N/A
- PRTA N/A
- Industry
- SPTN Food Distributors
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- PRTA Health Care
- Exchange
- SPTN Nasdaq
- PRTA Nasdaq
- Market Cap
- SPTN 746.4M
- PRTA 802.8M
- IPO Year
- SPTN N/A
- PRTA N/A
- Fundamental
- Price
- SPTN $18.76
- PRTA $14.60
- Analyst Decision
- SPTN Hold
- PRTA Buy
- Analyst Count
- SPTN 1
- PRTA 7
- Target Price
- SPTN $20.00
- PRTA $57.67
- AVG Volume (30 Days)
- SPTN 254.9K
- PRTA 509.1K
- Earning Date
- SPTN 11-07-2024
- PRTA 11-12-2024
- Dividend Yield
- SPTN 4.64%
- PRTA N/A
- EPS Growth
- SPTN 9.92
- PRTA N/A
- EPS
- SPTN 1.33
- PRTA N/A
- Revenue
- SPTN $9,532,883,000.00
- PRTA $133,350,000.00
- Revenue This Year
- SPTN N/A
- PRTA $60.63
- Revenue Next Year
- SPTN $2.04
- PRTA N/A
- P/E Ratio
- SPTN $14.12
- PRTA N/A
- Revenue Growth
- SPTN N/A
- PRTA N/A
- 52 Week Low
- SPTN $17.74
- PRTA $13.22
- 52 Week High
- SPTN $24.51
- PRTA $41.55
- Technical
- Relative Strength Index (RSI)
- SPTN 38.26
- PRTA 38.48
- Support Level
- SPTN $17.90
- PRTA $13.22
- Resistance Level
- SPTN $18.42
- PRTA $18.60
- Average True Range (ATR)
- SPTN 0.65
- PRTA 1.09
- MACD
- SPTN -0.06
- PRTA -0.22
- Stochastic Oscillator
- SPTN 17.19
- PRTA 24.84
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).